132 related articles for article (PubMed ID: 15763374)
21. Delayed parasite elimination in human infections treated with clindamycin parallels 'delayed death' of Plasmodium falciparum in vitro.
Burkhardt D; Wiesner J; Stoesser N; Ramharter M; Uhlemann AC; Issifou S; Jomaa H; Krishna S; Kremsner PG; Borrmann S
Int J Parasitol; 2007 Jun; 37(7):777-85. PubMed ID: 17280676
[TBL] [Abstract][Full Text] [Related]
22. Plasmodium falciparum and Plasmodium berghei: effect of magnesium on the development of parasitemia.
Hess FI; Kilian A; Söllner W; Nothdurft HD; Pröll S; Löscher T
Exp Parasitol; 1995 Mar; 80(2):186-93. PubMed ID: 7895830
[TBL] [Abstract][Full Text] [Related]
23. Enhanced activity of mefloquine and artesunic acid against Plasmodium falciparum in vitro and P. berghei in mice by combination with ciprofloxacin.
Andrade AA; de Pilla Varotti F; de Freitas IO; de Souza MV; Vasconcelos TR; Boechat N; Krettli AU
Eur J Pharmacol; 2007 Mar; 558(1-3):194-8. PubMed ID: 17214980
[TBL] [Abstract][Full Text] [Related]
24. In vitro and in vivo antiplasmodial activity and cytotoxicity of extracts of Phyllanthus niruri L. herbs traditionally used to treat malaria in Indonesia.
Mustofa ; Sholikhah EN; Wahyuono S
Southeast Asian J Trop Med Public Health; 2007 Jul; 38(4):609-15. PubMed ID: 17882995
[TBL] [Abstract][Full Text] [Related]
25. In vitro activity of ferroquine (SAR97193) is independent of chloroquine resistance in Plasmodium falciparum.
Kreidenweiss A; Kremsner PG; Dietz K; Mordmüller B
Am J Trop Med Hyg; 2006 Dec; 75(6):1178-81. PubMed ID: 17172389
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic effects of various solvent fractions of Alstonia boonei (apocynaceae) stem bark on Plasmodium berghei-induced malaria.
Olanlokun JO; Bolaji OM; Agbedahunsi JM; Olorunsogo OO
Afr J Med Med Sci; 2012 Dec; 41 Suppl():27-33. PubMed ID: 23678633
[TBL] [Abstract][Full Text] [Related]
27. Effective treatment of uncomplicated Plasmodium falciparum malaria with azithromycin-quinine combinations: a randomized, dose-ranging study.
Miller RS; Wongsrichanalai C; Buathong N; McDaniel P; Walsh DS; Knirsch C; Ohrt C
Am J Trop Med Hyg; 2006 Mar; 74(3):401-6. PubMed ID: 16525097
[TBL] [Abstract][Full Text] [Related]
28. The potential use of methotrexate in the treatment of falciparum malaria: in vitro assays against sensitive and multidrug-resistant falciparum strains.
Dar O; Khan MS; Adagu I
Jpn J Infect Dis; 2008 May; 61(3):210-1. PubMed ID: 18503171
[TBL] [Abstract][Full Text] [Related]
29. Reversal activity of the naturally occurring chemosensitizer malagashanine in Plasmodium malaria.
Rafatro H; Ramanitrahasimbola D; Rasoanaivo P; Ratsimamanga-Urverg S; Rakoto-Ratsimamanga A; Frappier F
Biochem Pharmacol; 2000 May; 59(9):1053-61. PubMed ID: 10704934
[TBL] [Abstract][Full Text] [Related]
30. Antimalarial dual drugs based on potent inhibitors of glutathione reductase from Plasmodium falciparum.
Friebolin W; Jannack B; Wenzel N; Furrer J; Oeser T; Sanchez CP; Lanzer M; Yardley V; Becker K; Davioud-Charvet E
J Med Chem; 2008 Mar; 51(5):1260-77. PubMed ID: 18260613
[TBL] [Abstract][Full Text] [Related]
31. Therapeutic efficacy of quinine plus sulfadoxine-pyremethamine for the treatment of uncomplicated falciparum malaria in Bangladesh.
Thriemer K; Haque R; Wagatsuma Y; Salam MA; Akther S; Attlmayr B; Fukuda M; Schaecher K; Miller RS; Noedl H
Am J Trop Med Hyg; 2006 Oct; 75(4):645-9. PubMed ID: 17038687
[TBL] [Abstract][Full Text] [Related]
32. Antimalarial activity of 4-(5-trifluoromethyl-1H-pyrazol-1-yl)-chloroquine analogues.
Cunico W; Cechinel CA; Bonacorso HG; Martins MA; Zanatta N; de Souza MV; Freitas IO; Soares RP; Krettli AU
Bioorg Med Chem Lett; 2006 Feb; 16(3):649-53. PubMed ID: 16257205
[TBL] [Abstract][Full Text] [Related]
33. Screening of medicinal plants from Reunion Island for antimalarial and cytotoxic activity.
Jonville MC; Kodja H; Humeau L; Fournel J; De Mol P; Cao M; Angenot L; Frédérich M
J Ethnopharmacol; 2008 Dec; 120(3):382-6. PubMed ID: 18848979
[TBL] [Abstract][Full Text] [Related]
34. Synthesis of three classes of rhodacyanine dyes and evaluation of their in vitro and in vivo antimalarial activity.
Pudhom K; Kasai K; Terauchi H; Inoue H; Kaiser M; Brun R; Ihara M; Takasu K
Bioorg Med Chem; 2006 Dec; 14(24):8550-63. PubMed ID: 16971131
[TBL] [Abstract][Full Text] [Related]
35. Antiplasmodial activity of root extract and fractions of Croton zambesicus.
Okokon JE; Nwafor PA
J Ethnopharmacol; 2009 Jan; 121(1):74-8. PubMed ID: 18996464
[TBL] [Abstract][Full Text] [Related]
36. Drug-resistant malaria in Bangui, Central African Republic: an in vitro assessment.
Menard D; Djalle D; Manirakiza A; Yapou F; Siadoua V; Sana S; Matsika-Claquin MD; Nestor M; Talarmin A
Am J Trop Med Hyg; 2005 Aug; 73(2):239-43. PubMed ID: 16103582
[TBL] [Abstract][Full Text] [Related]
37. Antimalarial effect of agmatine on Plasmodium berghei K173 strain.
Su RB; Wei XL; Liu Y; Li J
Acta Pharmacol Sin; 2003 Sep; 24(9):918-22. PubMed ID: 12956942
[TBL] [Abstract][Full Text] [Related]
38. Sulfadoxine-pyrimethamine plus artesunate compared with chloroquine for the treatment of vivax malaria in areas co-endemic for Plasmodium falciparum and P. vivax: a randomised non-inferiority trial in eastern Afghanistan.
Kolaczinski K; Durrani N; Rahim S; Rowland M
Trans R Soc Trop Med Hyg; 2007 Nov; 101(11):1081-7. PubMed ID: 17707447
[TBL] [Abstract][Full Text] [Related]
39. Real-time PCR assay for rapid detection and analysis of PfCRT haplotypes of chloroquine-resistant Plasmodium falciparum isolates from India.
Keen J; Farcas GA; Zhong K; Yohanna S; Dunne MW; Kain KC
J Clin Microbiol; 2007 Sep; 45(9):2889-93. PubMed ID: 17609321
[TBL] [Abstract][Full Text] [Related]
40. Clinical-parasitological response and in-vitro sensitivity of Plasmodium vivax to chloroquine and quinine on the western border of Thailand.
Tasanor O; Ruengweerayut R; Sirichaisinthop J; Congpuong K; Wernsdorfer WH; Na-Bangchang K
Trans R Soc Trop Med Hyg; 2006 May; 100(5):410-8. PubMed ID: 16497347
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
